← Back to technologies
Healthcare

Evimatic®: Scientific evidence analysis platform for ADHD interventions and treatment support

EntityUniversity of Girona (UdG) and Xarxa TECSAM (Innovation Network of New Technologies in Mental Health)
Project ManagerElisa Sáenz
TRL7
PublishedAugust 28, 2026

The growing volume of scientific publications on ADHD makes it increasingly difficult to stay fully up to date with the latest evidence. In addition, clinical guidelines can take years to be updated, while general-purpose AI tools may produce errors that are unacceptable in professional settings. A system capable of automatically and rigorously assessing the efficacy and safety of ADHD treatments, while accounting for the complexity of the disorder, provides significant added value to healthcare centres.

Evimatic® collects, structures and analyses dispersed scientific literature to support healthcare professionals. It is an interactive tool for assessing the efficacy and safety of ADHD treatments, enabling healthcare centres to optimise their decision-making protocols through AI. This positions them as leaders in excellence and innovation, capable of providing answers based on the latest scientific evidence.

Evimatic® is a scientific evidence analysis platform based on APPRAISE technology (Automated, uPdated, Participatory, peRsonAlISEd treatment Recommender System), an AI-based evidence analysis system that allows users to incorporate additional layers of reasoning or optimisation methods using machine learning techniques.

The platform provides:

  • Dynamic analysis of scientific evidence on the efficacy and safety of ADHD treatments.
  • Benefit-risk assessment of pharmacological and non-pharmacological treatments.
  • Treatment ranking based on parameters defined by the specialist.
  • Customisable analytical reasoning according to the healthcare professional’s criteria.
  • Sharing of customised configurations with third parties, extending its impact among ADHD specialists and generating economic returns.

Evimatic® is currently at TRL 7. Its technological validation and clinical evaluation have been carried out in the field of ADHD as a proof of concept, with potential future applications in other mental health conditions.

The platform has been implemented at the Institut d’Assistència Sanitària (IAS), the main mental health provider in the province of Girona. Its analytical reasoning is currently being customised for a consortium comprising the Catalan Societies of Child Psychiatry, Psychiatry and Mental Health, Clinical Psychology and Pharmacology.

The aim is to validate interest in the platform, identify the first early adopters of the technology and establish collaborations with key partners for the clinical evaluation of new functionalities.

Interested in this opportunity?

Contact us to discuss licensing, collaboration or the next steps.

Contact project